GE HealthCare Technologies/$GEHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ticker
$GEHC
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
53,000
ISIN
US36266G1076
Website
GEHC Metrics
BasicAdvanced
$35B
15.86
$4.76
1.38
$0.13
0.19%
Price and volume
Market cap
$35B
Beta
1.38
52-week high
$94.80
52-week low
$57.65
Average daily volume
3.6M
Dividend rate
$0.13
Financial strength
Current ratio
0.977
Quick ratio
0.7
Long term debt to equity
74.995
Total debt to equity
97.515
Dividend payout ratio (TTM)
2.61%
Interest coverage (TTM)
7.07%
Profitability
EBITDA (TTM)
3,761
Gross margin (TTM)
42.00%
Net profit margin (TTM)
11.03%
Operating margin (TTM)
15.60%
Effective tax rate (TTM)
18.51%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
6.07%
Return on equity (TTM)
26.44%
Valuation
Price to earnings (TTM)
15.863
Price to revenue (TTM)
1.74
Price to book
3.76
Price to tangible book (TTM)
-6.37
Price to free cash flow (TTM)
25.074
Free cash flow yield (TTM)
3.99%
Free cash flow per share (TTM)
301.15%
Dividend yield (TTM)
0.17%
Forward dividend yield
0.19%
Growth
Revenue change (TTM)
1.56%
Earnings per share change (TTM)
38.77%
3-year revenue growth (CAGR)
4.04%
3-year earnings per share growth (CAGR)
1.75%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
Bulls say / Bears say
GE HealthCare Technologies reported better-than-expected fourth-quarter revenue and provided an upbeat 2024 outlook, leading to an 11.5% rise in shares. (MarketScreener)
The company received FDA approval for expanded indications of its Vizamyl PET imaging agent, enhancing its capabilities in Alzheimer's disease diagnostics. (StockTitan)
GE HealthCare announced a cash dividend for the second quarter of 2025, reflecting confidence in its financial stability. (StockTitan)
GE HealthCare's stock declined by 12.9% in April due to new tariffs announced by President Donald Trump, impacting earnings projections. (The Motley Fool)
The company lowered its 2025 earnings and cash-flow expectations, citing an additional $0.80 per share impact from tariffs. (The Motley Fool)
Citigroup analysts reduced GE HealthCare's price target to $86.00, indicating potential concerns about future performance. (Techdows News)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
GEHC News
AllArticlesVideos
GE HealthCare announces cash dividend for second quarter of 2025
Business Wire·1 week ago
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients
Business Wire·2 weeks ago
GE HealthCare drives innovation in theranostics with latest technological advances
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul25
GE HealthCare Technologies
Dividend·Ex-dividend
Aug15
GE HealthCare Technologies
Dividend·Payment
$0.035Per share
FAQs
What’s the current market cap for GE HealthCare Technologies stock?
GE HealthCare Technologies (GEHC) has a market cap of $35B as of July 10, 2025.
What is the P/E ratio for GE HealthCare Technologies stock?
The price to earnings (P/E) ratio for GE HealthCare Technologies (GEHC) stock is 15.86 as of July 10, 2025.
Does GE HealthCare Technologies stock pay dividends?
Yes, the GE HealthCare Technologies (GEHC) stock pays dividends to shareholders. As of July 10, 2025, the dividend rate is $0.13 and the yield is 0.19%. GE HealthCare Technologies has a payout ratio of 2.61% on a trailing twelve-month basis.
When is the next GE HealthCare Technologies dividend payment date?
The next GE HealthCare Technologies (GEHC) dividend payment is scheduled for August 15, 2025.
What is the beta indicator for GE HealthCare Technologies?
GE HealthCare Technologies (GEHC) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.